drug · antibody
patient view →Cancer Program
Phase 2updated 2mo agoby Mirror Biologics Inc🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 9 approved and 146 investigational indications.
targets
Programmed cell death protein 1
all catalysts(0)
nothing on the calendar yet
News(1)
- Merck adds to pharma’s AI push; Roche details MS drug results<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…biopharma_dive · 2mo ago
comments(0)
5-min edit window · permanent after that